Capgemini-智能扩展：让GCC为中型医疗技术公司服务（英）-2025
for mid-size MedTech Over the past 12–18 months, at least eight major pharmaceutical and life sciences companies launched, or
报告摘要
for mid-size MedTech Over the past 12–18 months, at least eight major pharmaceutical and life sciences companies launched, or
报告信息
- 文件全名
- 《Capgemini-智能扩展：让GCC为中型医疗技术公司服务（英）-2025-16页.pdf》
- 适合读者
- 核心数据
- GCCs achieve a 20% annual cost decline
- 78% of newly established GCCs prioritize
- 85% of GCCs are forecasted to fully transition
- expected to power 75% of GCC operations.3
- 93% of GCC leaders have direct reporting lines to C-suite
- 核心议题
常见问题
《Capgemini-智能扩展：让GCC为中型医疗技术公司服务（英）-2025》主要包含哪些内容?
for mid-size MedTech Over the past 12–18 months, at least eight major pharmaceutical and life sciences companies launched, or核心数据:GCCs achieve a 20% annual cost decline;78% of newly established GCCs prioritize;85% of GCCs are forecasted to fully transition。
这份报告由哪家机构发布?
本报告由Capgemini发布,发布于 2025 年。
这份报告覆盖哪一年、篇幅多大?
覆盖 2025 年,全文约 16。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了医疗等议题。
继续阅读
查看全部 →